1. Home
  2. NNN vs RGEN Comparison

NNN vs RGEN Comparison

Compare NNN & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNN
  • RGEN
  • Stock Information
  • Founded
  • NNN 1984
  • RGEN 1981
  • Country
  • NNN United States
  • RGEN United States
  • Employees
  • NNN N/A
  • RGEN N/A
  • Industry
  • NNN Real Estate Investment Trusts
  • RGEN Medical/Dental Instruments
  • Sector
  • NNN Real Estate
  • RGEN Health Care
  • Exchange
  • NNN Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • NNN 7.6B
  • RGEN 7.6B
  • IPO Year
  • NNN N/A
  • RGEN N/A
  • Fundamental
  • Price
  • NNN $40.08
  • RGEN $160.51
  • Analyst Decision
  • NNN Hold
  • RGEN Buy
  • Analyst Count
  • NNN 9
  • RGEN 12
  • Target Price
  • NNN $46.38
  • RGEN $187.44
  • AVG Volume (30 Days)
  • NNN 1.2M
  • RGEN 521.6K
  • Earning Date
  • NNN 02-06-2025
  • RGEN 02-19-2025
  • Dividend Yield
  • NNN 5.79%
  • RGEN N/A
  • EPS Growth
  • NNN 1.10
  • RGEN N/A
  • EPS
  • NNN 2.16
  • RGEN N/A
  • Revenue
  • NNN $867,015,000.00
  • RGEN $633,513,000.00
  • Revenue This Year
  • NNN N/A
  • RGEN $2.28
  • Revenue Next Year
  • NNN $4.00
  • RGEN $9.88
  • P/E Ratio
  • NNN $18.55
  • RGEN N/A
  • Revenue Growth
  • NNN 6.99
  • RGEN N/A
  • 52 Week Low
  • NNN $37.55
  • RGEN $113.50
  • 52 Week High
  • NNN $49.57
  • RGEN $211.13
  • Technical
  • Relative Strength Index (RSI)
  • NNN 46.31
  • RGEN 62.61
  • Support Level
  • NNN $39.37
  • RGEN $150.23
  • Resistance Level
  • NNN $40.41
  • RGEN $160.64
  • Average True Range (ATR)
  • NNN 0.74
  • RGEN 6.76
  • MACD
  • NNN 0.15
  • RGEN 1.14
  • Stochastic Oscillator
  • NNN 74.85
  • RGEN 80.27

About NNN NNN REIT Inc.

NNN REIT Inc is a real estate investment trust that invests in and develops properties throughout the United States. The company generates revenue from leasing properties to tenants, including convenience stores, automotive services, fitness centers, theatres, restaurants, and banks. Rents from convenience stores and restaurants contribute the majority proportion of total revenue, followed by automotive services, entertainment venues, and others. maximum of the company's properties are located in the South and Southeast of the United States.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: